Engineering core
Character
OUT OF CHARACTER INFORMATION
- Intent: To create a genetic modifier.
- Image Source: X
- Permissions: N/A
- Primary Source: N/A
- Name: CGM
- Manufacturer: Conglomerate of Owls
- Affiliation: Arsenae
- Market Status: Closed-Market
- Modularity: N/A
- Production: Mass-Produced
- Material:
- Chloroplasts
- Durasteel and transparisteel container
- Genetic modifiers
- Plasma/platelets from person recieving the gene modification
- Classification: Gene modification
- Method of Consumption: Injection
- Average Life: indefinite
- Nutritional Value/Allergies/Side Effects/ Purpose: Genetic modifier that places chloroplasts in the patient's skin cells in order to make their bodies begin producing chlorophyll. Side effects are normally soreness of injection site and tiredness for the first few days.
- Chloroplasts modified from native plants of Arsenae
- Durasteel and transparisteel container
- Genetic modifiers to force cells to except new DNA strand
- Plasma/platelets from person recieving the gene modification to increase healing speed and limit chance of rejection.
- Chlorophyll production: The results of this gene modification makes the patients body produce chlorophyll like plants. This lets the body produce small amounts of sugar for energy, therefore cutting down some on food intake.
- Spread speed: CGM injections take time to spread after the initial injection. Solely relying on the body to keep producing new skin cells in order to spread.
- light contact: The chlorophyll from these injections can only produce sugars when exposed to light. Leaving them more effective in areas of high sun or parts of the body that aren't normally covered, hands, forearms, face.
CGM (chloroplast gene modification) was originally a genetic experiments on desert plants native to the planet Arsenae. These experiments lead to the discovery that chloroplasts from certain plants could be modified and injected into human cells, making them produce chlorophyll and begin photosynthesis. First trial experiments only made cells produce small amounts of chlorophyll and limited photosynthetic energy. After several more trial and error attempts, Arsenian scientists finally were able to get human cells to produce their own chloroplasts by rewriting part of the cell DNA and adding chloroplast DNA. This is achieved through small genetic modifiers that trick the cell into believing the chloroplast DNA is part of its own. During the time of injection, plasma and platelets from the recipient are added to the solution. This not only allows for the body to heal quicker, but also limits the chances of rejection.
The major application and use for this genetic modification was directed at space travel, orbital stations and in mines. With the addition of photosynthesis in the human body, the patient would produce needed energy in small amounts, making them require less food. This would help make food supplies last longer on vessels and stations. These applications soon transferred to many other situations, such as surviving on desert worlds or even general use by the public. Ships, survival and hard suits were equipped with u.v. lights to help with photosynthesis. A draw back is the amount of time it takes to spread through the cells of the recipient, resulting in the need for injections in several places such as hands, forearms and faces. Recipients also need to drink slightly more water than the average human.
